Vivesto Stock

Vivesto FCF Yield

The Free Cash Flow Yield of Vivesto (VIVE.ST) as of Aug 10, 2026 is -76.74 %. In the previous year, Free Cash Flow Yield was -89.33 % — a change of -14.10% (higher).

FCF Yield

-76.74 %

YoY

-14.10%

Last updated:

Free Cash Flow Yield of Vivesto is 2026 -76.74 % . Free Cash Flow Yield of Vivesto was 2025 -89.33 % . It decreases by -14.10% higher compared to the previous year.
Access this data via the Eulerpool API

Vivesto Stock analysis

What does Vivesto do? Oasmia Pharmaceutical AB is a Swedish pharmaceutical company that specializes in the development and marketing of innovative cancer and pain medications. The company was founded in 1998 and is headquartered in Uppsala, Sweden. Vivesto is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Vivesto stock

Free Cash Flow Yield of Vivesto is -76.74 % in 2026.

Free Cash Flow Yield of Vivesto changed from -89.33 % to -76.74 %, representing a -14.10% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Free Cash Flow Yield Vivesto since 2006 – with annual values, charts, and detailed analysis.

FCF Yield measures the free cash flow per share relative to the stock price. It indicates how much cash a company generates for each dollar invested.

To evaluate Free Cash Flow Yield's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Free Cash Flow Yield.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Free Cash Flow Yield's Vivesto with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

Valuation — Vivesto

All Key Metrics — Vivesto